Following our previous findings, we further demonstrate the efficacy of mTOR inhibitor rapamycin in the amelioration of the pathogenesis in GLD by reduction of protein aggregates, amelioration of neuroinflammation, and the preservation of the myeloarchitecture of cortical neurites in twitcher mice. The gene discussed is MTOR; the disease is Krabbe disease.